The decision means many Americans without underlying conditions may not have access to updated shots this fall."I think we have to admit to ourselves that America is deeply divided on the policy issue of repeat COVID-19 vaccine doses or boosters,

The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under age 65, effectively limiting them to older adults and those at risk of developing severe illness.

In a major policy shift, federal health officials anticipate the shots will be made available to adults 65 and older as well as children and younger adults who have one or more risk factors that make them more vulnerable to severe COVID-19.